Pharmacokinetics of Intravenously (DIZ101), Subcutaneously (DIZ102), and Intestinally (LCIG) Infused Levodopa in Advanced Parkinson Disease

BACKGROUND AND OBJECTIVES: Intestinal levodopa/carbidopa gel infusion (LCIG) is superior to oral treatment in advanced Parkinson disease. The primary objective of this trial was to investigate whether continuous subcutaneous or intravenous infusion with a continuously buffered acidic levodopa/carbid...

Descripción completa

Detalles Bibliográficos
Autores principales: Bergquist, Filip, Ehrnebo, Mats, Nyholm, Dag, Johansson, Anders, Lundin, Fredrik, Odin, Per, Svenningsson, Per, Hansson, Fredrik, Bring, Leif, Eriksson, Elias, Dizdar, Nil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519246/
https://www.ncbi.nlm.nih.gov/pubmed/35705502
http://dx.doi.org/10.1212/WNL.0000000000200804

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519246/
https://www.ncbi.nlm.nih.gov/pubmed/35705502
http://dx.doi.org/10.1212/WNL.0000000000200804

Ejemplares similares